Anti-Ro/SS-A and anti-La/SS-B antibodies are present in between 70% to 90% and 30% to 40%, respectively, of SCLE cases, and in up to 25% and 5%, respectively, of DLE cases. This evidence concerns the gene TRIM21 and discoid lupus erythematosus.